Article Per Year (5 Year)
p-Index From 2021 - 2026
0.23
P-Index
This Author published in this journals
All Journal Jurnal Ekonomi, Manajemen, Bisnis dan Akuntansi (JEMBA)
Audia Triani Ollii
Universitas Muslim Indonesia
Economics, Econometrics & Finance

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
ANALISIS MANAJEMEN SIKLUS OBAT ANTIHIPERTENSI DAN DAMPAKNYA TERHADAP KETERSEDIAAN DI INSTALASI FARMASI RAWAT JALAN RSU AT MEDIKA Muhammad Irvan Akbar Nur; Ahmad Najib; Audia Triani Ollii
JEMBA: JURNAL EKONOMI, MANAJEMEN, BISNIS DAN AKUNTANSI Vol. 5 No. 4 (2026): Juli 2026
Publisher : Bajang Institute

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

The implementation of National Health Insurance mandates hospitals to ensure the availability of essential medicines, yet recurring antihypertensive drug stockouts persist at RSU AT Medika. This study examines drug cycle management implementation, its impact on availability, and the influencing factors. Employing a descriptive qualitative approach with a single case study design, data were collected through in-depth interviews with 7 pharmacy informants and 15 hypertensive patients who had experienced stockouts, participatory observation, and document review from January to December 2025. Thematic analysis with data saturation and source triangulation was applied, assisted by NVivo software. The findings reveal that formal procedures have been executed according to standards, yet significant gaps exist between administrative compliance and operational reality. Planning based on historical data frequently proves inaccurate due to patient surges, while procurement through the hierarchical e-Catalog system constitutes the primary source of delays due to stock discrepancies. Stockout has been normalized as commonplace, disrupting patient therapy, burdening staff psychologically, and posing medico-legal risks. JKN regulation through e-Catalog presents a paradox: suppressing prices while hindering availability. The study concludes that antihypertensive drug availability is not merely logistical, but concerns patient safety and JKN system effectiveness.
Co-Authors Ahmad Najib Muhammad Irvan Akbar Nur